CTDP1

Chr 18AR

CTD phosphatase subunit 1

Also known as: CCFDN, FCP1

This gene encodes a phosphatase that dephosphorylates the C-terminal domain of RNA polymerase II to promote transcription initiation and also dephosphorylates key substrates required for mitotic exit. Mutations cause congenital cataracts, facial dysmorphism, and neuropathy (CCFDN), an autosomal recessive disorder with early-onset features affecting the eyes, craniofacial development, and peripheral nervous system. The gene is highly intolerant to loss-of-function variants (LOEUF 0.529), indicating strong selective pressure against haploinsufficiency.

OMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismARLOEUF 0.531 OMIM phenotype
Clinical SummaryCTDP1
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.33) despite low pLI — interpret in context.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.53LOEUF
pLI 0.001
Z-score 3.86
OE 0.33 (0.220.53)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
1.00Z-score
OE missense 0.88 (0.820.95)
501 obs / 567.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.33 (0.220.53)
00.351.4
Missense OE0.88 (0.820.95)
00.61.4
Synonymous OE1.12
01.21.6
LoF obs/exp: 13 / 39.0Missense obs/exp: 501 / 567.8Syn Z: -1.50

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

CTDP1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →